Tech Company Financing Transactions
Stellaromics Funding Round
Plaisance Capital Management and private investors participated in a $25 million Series A funding round for Stellaromics. The round closed on 11/2/2023.
Transaction Overview
Company Name
Announced On
11/2/2023
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to consolidate the business and establish a new headquarters to house its growing team of innovators. They will continue to focus on advancing the development of its revolutionary Plexa� products; the alpha version is expected to be available via a Technology Access Program in early 2024.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
21 Strathmore Rd
Natick, MA 01760
USA
Natick, MA 01760
USA
Phone
Website
Email Address
Overview
Stellaromics was founded in 2022 by a team of world renowned scientists on a mission to move biomedical research forward faster. The Plexa suite of products was developed to extend their progress by empowering others to innovate alongside them. With Plexa, any researcher or clinician can create fully annotated cellular maps for clearer understanding of disease progression and response to therapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Todd Dickinson
Chief Technical Officer
Ye Fu
Co-Founder
Christopher Kroeger
Browse more venture capital transactions:
Prev: 11/2/2023: Trips venture capital transaction
Next: 11/2/2023: Finkargo venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs